WHO ICTRP trial

Prospective Institutional review trial to test de novo sirolimus monotherapy…

DRKS00000858 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00000858
Public title Prospective Institutional review trial to test de novo sirolimus monotherapy following antithmocyte globin induction in kidney transplant recipients
Scientific title Prospective Institutional review trial to test de novo sirolimus monotherapy following antithmocyte globin induction in kidney transplant recipients
Primary sponsor Universitätsklinikum Freiburg Klinik für Allgemein und Vizeralchirurgie
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type interventional
Phase 3
Countries Germany
Conditions N18.8 Z94.0;Kidney transplant status;N18.8;Z94.0
Interventions Group 1: 15 well-selected immunologically low-risk patients receive a minimized immunsuppressive regime after kidney transplantation. The immunsupression starts with antithymocyte globin induction following de novo sirollmus monotherapy…
Registration date Apr 25, 2012
Target size 15
Secondary IDs UKF000105
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations